IC
SRNE

InterOcean Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

InterOcean Capital’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$63K Buy
+10,000
New +$38.3K ﹤0.01% 187
2019
Q4 		– Sell
-11,500
Closed -$25K – 210
2019
Q3 		$25K Buy
+11,500
New +$26.8K ﹤0.01% 199
2019
Q1 		– Sell
-10,550
Closed -$25K – 184
2018
Q4 		$25K Buy
+10,550
New +$34.5K ﹤0.01% 174

Other funds holding SRNE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

InterOcean Capital's SRNE Position: Q2 2020 in Review

InterOcean Capital opened a new position in Sorrento Therapeutics, Inc. (SRNE) in Q2 2020: 10,000 shares worth $63K. The stake represents ﹤0.01% of the portfolio and ranks #187 among its holdings. This is a return to the name: InterOcean Capital previously reported a position in SRNE as recently as Q3 2019.

InterOcean Capital first reported a position in SRNE in Q4 2018 and has held it in 3 quarters since. 186 funds tracked by Wall St. Rank hold SRNE as of Q2 2020.

  • InterOcean Capital held 10,000 shares of Sorrento Therapeutics, Inc. worth $63K as of Q2 2020.
  • Sorrento Therapeutics, Inc. was a new InterOcean Capital position in Q2 2020.
  • Sorrento Therapeutics, Inc. made up ﹤0.01% of InterOcean Capital's portfolio in Q2 2020, its #187 holding.
  • InterOcean Capital first reported a position in Sorrento Therapeutics, Inc. in Q4 2018 and has held it in 3 quarters since.
  • 186 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2020.

Based on InterOcean Capital's 13F filing for Q2 2020, filed 13 Aug 2020.